Evans School Policy Analysis & Research Group (EPAR)

The share of private sector funding, relative to public sector funding, for drug, vaccine, and diagnostic research & development (R&D) differs considerably across diseases. Private sector investment in overall health R&D exceeds $150 billion annually, but is largely concentrated on non-communicable chronic diseases with only an estimated $5.9 billion focused on "global health", targeting diseases that primarily affect low and middle-income countries (LMICs). We examine the evidence for five specific disincentives to private sector global health R&D investment: scientific uncertainty, weak policy environments, limited revenues and market uncertainty, high fixed and sunk costs, and downstream rents from imperfect markets. Though all five may affect estimates of net returns from an investment decision, they are worth examining separately as each calls for a different intervention or remediation to change behavior.

Data on public expenditures on agriculture are not systematically collected in any one database. Rather, a variety of sources collect and publish data on certain aspects of agricultural public expenditures. These sources vary in their data collection methods, their frequency of data collection, and the specific expenditures they report on. We collected data on agricultural public expenditures and conducted preliminary analyses for four countries: India (with a focus on Bihar, Odisha, and Uttar Pradesh), Ethiopia, Nigeria, and Tanzania. The data are disaggregated in a variety of ways depending on the source, but we include disaggregated data where available comparing planned or budgeted vs. actual spending, government vs. donor spending, soending by activity or funding area, and spending by commodity or value chain activity. Our goals are to facilitate further analysis of trends in agricultural public expenditures across countries and over time, and to highlight gaps and differences in data sources.

Cassava is a tuber crop originating in South America and grown in tropical and subtropical areas throughout the world. Cassava use varies significantly by region. In Africa, cassava is primarily grown for food. In Asia, production is typically for industrial purposes, including ethanol, while in Latin America and the Caribbean it is commonly used in animal feed. Both roots and leaves are consumed, though most information on production focuses on roots. There are bitter and sweet varieties; bitter cassava has a high cyanide content and must be processed prior to consumption, while sweet varieties can be eaten directly. This report presents information about current production, constraints, and future potential of cassava. We discuss cassava’s importance in Africa, current worldwide production, projections for supply and demand, production constraints, and current policies affecting cassava production and trade. We include global information but focus on Africa, particularly Nigeria, Ghana, Uganda, and Tanzania.